| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/DMRR.541 |
| P698 | PubMed publication ID | 15747389 |
| P2093 | author name string | Hideki Kamiya | |
| Anders A F Sima | |||
| Weixian Zhang | |||
| Yuichi Murakawa | |||
| P2860 | cites work | Neuropathic pain and diabetes | Q30768015 |
| The natural history of acute painful neuropathy in diabetes mellitus | Q33618804 | ||
| Neuropathic pain: aetiology, symptoms, mechanisms, and management | Q33661273 | ||
| The p75 neurotrophin receptor and neuronal apoptosis | Q33855419 | ||
| C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes | Q33982488 | ||
| Pain mechanisms and management: a central perspective | Q34051148 | ||
| Neurobiology of neuropathic pain: mode of action of anticonvulsants | Q34558542 | ||
| Understanding the impact of painful diabetic neuropathy. | Q35063564 | ||
| New insights into the metabolic and molecular basis for diabetic neuropathy | Q35587985 | ||
| Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells | Q36258189 | ||
| Pain in peripheral neuropathy related to rate and kind of fiber degeneration | Q39986690 | ||
| Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide | Q40552108 | ||
| C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells | Q40638427 | ||
| Glutamate: a role in normal brain function, anaesthesia, analgesia and CNS injury | Q41524392 | ||
| Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy | Q43611275 | ||
| Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve | Q43649927 | ||
| Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy | Q43687920 | ||
| The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy | Q43700620 | ||
| Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy | Q43780632 | ||
| GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats | Q43865201 | ||
| Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy | Q44240871 | ||
| Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy | Q44262556 | ||
| Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study | Q44282498 | ||
| Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. | Q44527074 | ||
| Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration | Q44538902 | ||
| Sensory neurons with activated caspase-3 survive long-term experimental diabetes | Q44564049 | ||
| Altered temporal pattern of mechanically evoked C-fiber activity in a model of diabetic neuropathy in the rat | Q44633576 | ||
| Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy | Q44937306 | ||
| Direct insulin signaling of neurons reverses diabetic neuropathy | Q44953938 | ||
| Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor | Q46191361 | ||
| Nerve growth factor administration protects against experimental diabetic sensory neuropathy | Q48190313 | ||
| Near nerve local insulin prevents conduction slowing in experimental diabetes | Q48655775 | ||
| Tetrodotoxin-resistant sodium channels of dorsal root ganglion neurons are readily activated in diabetic rats. | Q51462272 | ||
| Facilitation of the withdrawal reflex by repeated transcutaneous electrical stimulation: an experimental study on central integration in humans. | Q52171685 | ||
| Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy. | Q52206001 | ||
| Neurons undergo apoptosis in animal and cell culture models of diabetes. | Q52536719 | ||
| Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain. | Q54130898 | ||
| Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology | Q68137459 | ||
| Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration | Q68859452 | ||
| Piroxicam may reduce the rate of progression of experimental diabetic neuropathy | Q68899444 | ||
| The low-affinity nerve growth factor receptor p75NGFR mediates death of PC12 cells after nerve growth factor withdrawal | Q71618387 | ||
| Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor | Q71620117 | ||
| Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment | Q71669978 | ||
| Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy | Q73131425 | ||
| Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons | Q73142209 | ||
| Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat | Q73225634 | ||
| Alpha1-adrenoceptors involvement in painful diabetic neuropathy: a role in allodynia | Q73859496 | ||
| Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology | Q73885717 | ||
| A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats | Q74040792 | ||
| Early gene responses of trophic factors in nerve regeneration differ in experimental type 1 and type 2 diabetic polyneuropathies | Q78394667 | ||
| P433 | issue | 5 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 448-458 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes | |
| P478 | volume | 21 |
| Q31121713 | Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data |
| Q38822212 | Alternatives to the Streptozotocin-Diabetic Rodent. |
| Q27028046 | Animal models of peripheral neuropathies |
| Q51163071 | C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. |
| Q43159118 | Characterization of upper thoracic spinal neurons responding to esophageal distension in diabetic rats |
| Q36535440 | Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model |
| Q92501693 | Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti-inflammatory, neuroprotective and angiogenic actions: Cell-free regenerative medicine for diabetic polyneuropathy |
| Q79263476 | Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats |
| Q33554384 | Diabetic neuropathy: mechanisms to management |
| Q37605348 | Diabetic painful and insensate neuropathy: pathogenesis and potential treatments |
| Q41945335 | Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes |
| Q41457878 | Extracellular signal-regulated protein kinase activation in spinal cord contributes to pain hypersensitivity in a mouse model of type 2 diabetes |
| Q27313058 | High energy diets-induced metabolic and prediabetic painful polyneuropathy in rats |
| Q84605487 | Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries |
| Q42908853 | Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain |
| Q35184731 | Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. |
| Q37078507 | Pathogenesis of pain in peripheral diabetic neuropathy |
| Q36684873 | Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes |
| Q33677202 | Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice |
| Q37663812 | The beneficial effects of C-Peptide on diabetic polyneuropathy |
| Q37147785 | The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat |
| Q46273760 | Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia |
Search more.